MARKET

OBLN

OBLN

Obalon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8750
+0.0450
+5.42%
Opening 15:25 09/25 EDT
OPEN
0.8100
PREV CLOSE
0.8300
HIGH
0.9068
LOW
0.8100
VOLUME
73.04K
TURNOVER
--
52 WEEK HIGH
2.240
52 WEEK LOW
0.6200
MARKET CAP
6.77M
P/E (TTM)
-0.3542
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Morgan Stanley reports 5.9% stake in Obalon Therapeutics
Morgan Stanley reports 5.9% passive stake in Obalon Therapeutics (OBLN) +8% representing 456K shares.SC 13G
Seekingalpha · 09/01 12:39
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
GlobeNewswire · 08/13 12:00
Obalon Announces Second Quarter 2020 Financial Results
GlobeNewswire · 07/30 11:38
Obalon Therapeutics EPS misses by $0.24
Seeking Alpha · 07/30 11:27
EVC, IMRN, NES and SJT among midday movers
Seeking Alpha - Article · 06/19 16:41
Obalon's retail treatment centers to remain shut; delays shipments
Seeking Alpha - Article · 06/19 12:30
Obalon Announces First Quarter 2020 Financial Results and Business Update
GlobeNewswire · 06/19 11:15
Obalon Therapeutics Q1 EPS $(0.68) Up From $(3.59) YoY, Sales $780.00K Down From $1.77M YoY
Obalon Therapeutics (NASDAQ:OBLN) reported quarterly losses of $(0.68) per share. This is a 81.06 percent increase over losses of $(3.59) per share from the same period last year. The company reported $780.00 thousand
Benzinga · 06/19 10:17
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OBLN. Analyze the recent business situations of Obalon through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OBLN stock price target is 0.7500 with a high estimate of 0.7500 and a low estimate of 0.7500.
EPS
Institutional Holdings
Institutions: 36
Institutional Holdings: 1.14M
% Owned: 14.73%
Shares Outstanding: 7.73M
TypeInstitutionsShares
Increased
3
2.71K
New
8
-230.64K
Decreased
2
137.09K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.95%
Healthcare Equipment & Supplies
+1.96%
Key Executives
Chairman/President/Chief Executive Officer/Director
Andrew Rasdal
Vice President - Finance
Nooshin Hussainy
Vice President - Operations
Steve Johnson
Vice President/Director of Sales
Matthew Norwood
Vice President/Director of Marketing
Lisa Metzner
Vice President
Todd Wood
Vice President
Donald Young
Other
Robert MacDonald
Director
William Plovanic
Independent Director
Raymond Dittamore
Other
Bob MacDonald
Independent Director
Douglas Fisher
Independent Director
Lesley Howe
Independent Director
Sharon Stevenson
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About OBLN
Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Obalon Therapeutics Inc stock information, including NASDAQ:OBLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBLN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OBLN stock methods without spending real money on the virtual paper trading platform.